BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8721557)

  • 1. Combination therapy with zidovudine, didanosine and saquinavir.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett R; Baruch A; Corey L
    Antiviral Res; 1996 Jan; 29(1):99. PubMed ID: 8721557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
    N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with saquinavir.
    Vella S
    AIDS; 1995 Dec; 9 Suppl 2():S21-S25. PubMed ID: 8775803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.
    Revicki DA; Moyle G; Stellbrink HJ; Barker C
    AIDS; 1999 May; 13(7):851-8. PubMed ID: 10357386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
    Vella S; Galluzzo C; Giannini G; Pirillo MF; Duncan I; Jacobsen H; Andreoni M; Sarmati L; Ercoli L
    Antiviral Res; 1996 Jan; 29(1):91-3. PubMed ID: 8721555
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.
    Albrecht MA; Hughes MD; Liou SH; Katzenstein DA; Murphy R; Balfour HH; Para MF; Valdez H; Hammer SM;
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1337-44. PubMed ID: 11018853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritonavir: first to prolong survival.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipping HIV in the bud.
    Smart T
    GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV therapy advances. Update on a proteinase inhibitor.
    Vella S
    AIDS; 1994 Sep; 8 Suppl 3():S25-9. PubMed ID: 7840913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which is the strategy? The latest in the use of antiretrovirals].
    Agosto M
    Sidahora; 1995; ():33-4. PubMed ID: 11363205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV.
    Mauss S; Adams O; Willers R; Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):469-77. PubMed ID: 8605592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3TC and saquinavir: we need them now.
    Baker R
    BETA; 1995 Sep; ():3. PubMed ID: 11362889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference highlight.
    J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):26. PubMed ID: 11362749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.